首页> 外文期刊>International Journal of Pharmaceutical Sciences Review and Research >The Emerging Usage and Applications of Nanotechnology in Food Processing Industries: The new age of Nanofood
【24h】

The Emerging Usage and Applications of Nanotechnology in Food Processing Industries: The new age of Nanofood

机译:纳米技术在食品加工业中的新兴使用和应用:纳米食品的新时代

获取原文
           

摘要

Scopoletin, a derivative of coumarin, is a benzopyrone in nature, and present in the various plants. In the present study, scopoletin at a dose of 1mg/kg p.o. once a day and scopoletin at a dose of 1mg/kg p.o. at two times in a day was evaluated for the hypoglycemic and hypolipidemic activity in Wistar albino rats in streptozotocin induced diabetic rats. Glimepiride (0.11mg/kg) was used as reference standard for the activity comparison. Fasting blood glucose level and plasma lipid profiles were measured in diabetic and non diabetic rats at the end of the experiment. Scopoletin showed significant reduction in blood glucose level and lipid level in streptozotocin induced diabetic rats that is comparable to Glimepiride, with more promising decrease in glucose concentration observed in scopoletin two times a day than the scopoletin given once a day. The finding of the present investigation showed that the scopoletin at 1mg/kg dose is very helpful in diabetes and its complication. It showed the significant anti hyperglycemic and anti hyperlipidemic activity in Streptozotocin induced diabetic rats.
机译:香豆素是香豆素的衍生物,本质上是苯并吡喃酮,存在于各种植物中。在本研究中,东碱的剂量为1mg / kgp.o。每天一次,并以大剂量1mg / kg p.o.一天两次评估链脲佐菌素诱导的糖尿病大鼠中Wistar白化病大鼠的降血糖和降血脂活性。格列美脲(0.11mg / kg)用作活性比较的参考标准。实验结束时,在糖尿病和非糖尿病大鼠中测量空腹血糖水平和血浆脂质谱。在链脲佐菌素诱导的糖尿病大鼠中,Scopoletin显示出血糖水平和血脂水平的显着降低,与格列美脲相当,与每天一次的scopoletin相比,每天两次观察到scopoletin的血糖浓度降低的可能性更大。本研究的发现表明,以1mg / kg剂量的大麦pole碱对糖尿病及其并发症非常有帮助。它在链脲佐菌素诱导的糖尿病大鼠中显示出显着的抗高血糖和高血脂活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号